Literature DB >> 25139987

Efficient utilization of complex N-linked glycans is a selective advantage for Bacteroides fragilis in extraintestinal infections.

Yanlu Cao1, Edson R Rocha1, C Jeffrey Smith2.   

Abstract

Bacteroides fragilis is the most common anaerobe isolated from clinical infections, and in this report we demonstrate a characteristic of the species that is critical to their success as an opportunistic pathogen. Among the Bacteroides spp. in the gut, B. fragilis has the unique ability of efficiently harvesting complex N-linked glycans from the glycoproteins common to serum and serous fluid. This activity is mediated by an outer membrane protein complex designated as Don. Using the abundant serum glycoprotein transferrin as a model, it has been shown that B. fragilis alone can rapidly and efficiently deglycosylate this protein in vitro and that transferrin glycans can provide the sole source of carbon and energy for growth in defined media. We then showed that transferrin deglycosylation occurs in vivo when B. fragilis is propagated in the rat tissue cage model of extraintestinal growth, and that this ability provides a competitive advantage in vivo over strains lacking the don locus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25139987      PMCID: PMC4156730          DOI: 10.1073/pnas.1407344111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Characterization of a gene cluster for sialoglycoconjugate utilization in Bacteroides fragilis.

Authors:  Haruyuki Nakayama-Imaohji; Minoru Ichimura; Tomoya Iwasa; Natsumi Okada; Yoshinari Ohnishi; Tomomi Kuwahara
Journal:  J Med Invest       Date:  2012

2.  EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis.

Authors:  Mattias Collin; Mikael D Svensson; Anders G Sjöholm; Jens C Jensenius; Ulf Sjöbring; Arne Olsén
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  The long-term stability of the human gut microbiota.

Authors:  Jeremiah J Faith; Janaki L Guruge; Mark Charbonneau; Sathish Subramanian; Henning Seedorf; Andrew L Goodman; Jose C Clemente; Rob Knight; Andrew C Heath; Rudolph L Leibel; Michael Rosenbaum; Jeffrey I Gordon
Journal:  Science       Date:  2013-07-05       Impact factor: 47.728

4.  Comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion.

Authors:  Jun-ichi Furukawa; Yasuro Shinohara; Hiromitsu Kuramoto; Yoshiaki Miura; Hideyuki Shimaoka; Masaki Kurogochi; Mika Nakano; Shin-Ichiro Nishimura
Journal:  Anal Chem       Date:  2008-01-19       Impact factor: 6.986

5.  Effects of neutrophils on cefazolin activity and penicillin-binding proteins in Staphylococcus aureus abscesses.

Authors:  David M Bamberger; Betty L Herndon; Jeffrey Fitch; Aaron Florkowski; Vera Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

6.  The Bacteroides fragilis transcriptome response to oxygen and H2O2: the role of OxyR and its effect on survival and virulence.

Authors:  Christian J Sund; Edson R Rocha; Arthur O Tzianabos; Arthur O Tzinabos; W Greg Wells; Jason M Gee; Michael A Reott; Dorcas P O'Rourke; C Jeffrey Smith
Journal:  Mol Microbiol       Date:  2007-11-28       Impact factor: 3.501

7.  Sialic acid (N-acetyl neuraminic acid) utilization by Bacteroides fragilis requires a novel N-acetyl mannosamine epimerase.

Authors:  Christopher Brigham; Ruth Caughlan; Rene Gallegos; Mary Beth Dallas; Veronica G Godoy; Michael H Malamy
Journal:  J Bacteriol       Date:  2009-03-20       Impact factor: 3.490

8.  Reemergence of anaerobic bacteremia.

Authors:  Britta Lassmann; Daniel R Gustafson; Christina M Wood; Jon E Rosenblatt
Journal:  Clin Infect Dis       Date:  2007-02-14       Impact factor: 9.079

9.  The N-glycan glycoprotein deglycosylation complex (Gpd) from Capnocytophaga canimorsus deglycosylates human IgG.

Authors:  Francesco Renzi; Pablo Manfredi; Manuela Mally; Suzette Moes; Paul Jenö; Guy R Cornelis
Journal:  PLoS Pathog       Date:  2011-06-30       Impact factor: 6.823

10.  Expression of Bacteroides fragilis hemolysins in vivo and role of HlyBA in an intra-abdominal infection model.

Authors:  Leandro A Lobo; Audrey L Jenkins; C Jeffrey Smith; Edson R Rocha
Journal:  Microbiologyopen       Date:  2013-02-26       Impact factor: 3.139

View more
  23 in total

1.  cis-Encoded Small RNAs, a Conserved Mechanism for Repression of Polysaccharide Utilization in Bacteroides.

Authors:  Yanlu Cao; Konrad U Förstner; Jörg Vogel; C Jeffrey Smith
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

2.  Small RNAs Repress Expression of Polysaccharide Utilization Loci of Gut Bacteroides Species.

Authors:  Laurie E Comstock
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

3.  The N-Glycan cluster from Xanthomonas campestris pv. campestris: a toolbox for sequential plant N-glycan processing.

Authors:  Stéphanie Dupoiron; Claudine Zischek; Laetitia Ligat; Julien Carbonne; Alice Boulanger; Thomas Dugé de Bernonville; Martine Lautier; Pauline Rival; Matthieu Arlat; Elisabeth Jamet; Emmanuelle Lauber; Cécile Albenne
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

4.  The uroS and yifB Genes Conserved among Tetrapyrrole Synthesizing-Deficient Bacteroidales Are Involved in Bacteroides fragilis Heme Assimilation and Survival in Experimental Intra-abdominal Infection and Intestinal Colonization.

Authors:  Anita C Parker; Hector A Bergonia; Nathaniel L Seals; Cecile L Baccanale; Edson R Rocha
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

5.  Dps and DpsL Mediate Survival In Vitro and In Vivo during the Prolonged Oxidative Stress Response in Bacteroides fragilis.

Authors:  Michael I Betteken; Edson R Rocha; C Jeffrey Smith
Journal:  J Bacteriol       Date:  2015-08-10       Impact factor: 3.490

6.  A unique combination of glycoside hydrolases in Streptococcus suis specifically and sequentially acts on host-derived αGal-epitope glycans.

Authors:  Ping Chen; Ran Liu; Mengmeng Huang; Jinlu Zhu; Dong Wei; Francis J Castellino; Guanghui Dang; Fang Xie; Gang Li; Ziyin Cui; Siguo Liu; Yueling Zhang
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

7.  Complex N-glycan breakdown by gut Bacteroides involves an extensive enzymatic apparatus encoded by multiple co-regulated genetic loci.

Authors:  Justina Briliūtė; Paulina A Urbanowicz; Ana S Luis; Arnaud Baslé; Neil Paterson; Osmond Rebello; Jenifer Hendel; Didier A Ndeh; Elisabeth C Lowe; Eric C Martens; Daniel I R Spencer; David N Bolam; Lucy I Crouch
Journal:  Nat Microbiol       Date:  2019-06-03       Impact factor: 17.745

8.  Functional genetics of human gut commensal Bacteroides thetaiotaomicron reveals metabolic requirements for growth across environments.

Authors:  Hualan Liu; Anthony L Shiver; Morgan N Price; Hans K Carlson; Valentine V Trotter; Yan Chen; Veronica Escalante; Jayashree Ray; Kelsey E Hern; Christopher J Petzold; Peter J Turnbaugh; Kerwyn Casey Huang; Adam P Arkin; Adam M Deutschbauer
Journal:  Cell Rep       Date:  2021-03-02       Impact factor: 9.423

9.  How members of the human gut microbiota overcome the sulfation problem posed by glycosaminoglycans.

Authors:  Alan Cartmell; Elisabeth C Lowe; Arnaud Baslé; Susan J Firbank; Didier A Ndeh; Heath Murray; Nicolas Terrapon; Vincent Lombard; Bernard Henrissat; Jeremy E Turnbull; Mirjam Czjzek; Harry J Gilbert; David N Bolam
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

10.  Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients.

Authors:  Leila B Giron; Harsh Dweep; Xiangfan Yin; Han Wang; Mohammad Damra; Aaron R Goldman; Nicole Gorman; Clovis S Palmer; Hsin-Yao Tang; Maliha W Shaikh; Christopher B Forsyth; Robert A Balk; Netanel F Zilberstein; Qin Liu; Andrew Kossenkov; Ali Keshavarzian; Alan Landay; Mohamed Abdel-Mohsen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.